Beth A. Hellerstedt, MD works in the field of Oncology. He attended University of Pittsburgh School of Medicine. He received 3 awards: "Meaningful Use Stage 1 Certification", "Top MD" and "Super Doctor". Beth A. Hellerstedt, MD is a published doctor and has 7 publications published. The lastest was: 'Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer.' Beth Hellerstedt is registered with Medicare and accepts Medicare payments.
NPI NUMBER | 1215975487 | |
NPPES Provider LastName | HELLERSTEDT | |
NPPES Provider FirstName | BETH | |
NPPES Provider ZIPCode | 787314214 | |
NPPES Provider State | TX | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 2128.0 | |
Distinct Opioid Count | 7.0 | |
Opioid Claim Count | 208.0 | |
Percent Opioid Claims | 9.77 |
National Provider Identifier [NPI] | 1215975487 |
Last Name Of The Provider | HELLERSTEDT |
First Name Of The Provider | BETH |
View All |
Dr. David W. George, MD | |
Dr. Christal E. Murray, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Lesley E. Hamilton-Fox, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Stephen T. Traweek II, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |